These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6761907)

  • 1. Evidence for the presence of circulating immune complexes in serum and C3b and C3d on red cells of kala-azar patients.
    Kharazmi A; Rezai HR; Fani M; Behforouz NC
    Trans R Soc Trop Med Hyg; 1982; 76(6):793-6. PubMed ID: 6761907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic findings in juvenile Mediterranean kala-azar].
    Koletzko B; von Kries R; Wahn V
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):96-9. PubMed ID: 6328286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes in Indian kala-azar.
    Sehgal S; Aikat BK; Pathania AG
    Bull World Health Organ; 1982; 60(6):945-50. PubMed ID: 6761008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
    Theofilopoulos AN; Dixon FJ; Bokisch VA
    J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological features of kala-azar.
    Rezai HR; Ardehali SM; Amirhakimi G; Kharazmi A
    Am J Trop Med Hyg; 1978 Nov; 27(6):1079-83. PubMed ID: 310248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of C3 subcomponents on red cells coated with complement in vitro.
    Freedman J; Massey A
    J Clin Pathol; 1980 Oct; 33(10):977-83. PubMed ID: 7430364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological profiles in Indian post kala-azar dermal leishmaniasis.
    Haldar JP; Saha KC; Ghose AC
    Trans R Soc Trop Med Hyg; 1981; 75(4):514-7. PubMed ID: 7324125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological findings in kala-azar, Iran.
    Behforouz NC; Amirhakimi GH; Rezai HR; Saberi MS
    Trop Geogr Med; 1983 Mar; 35(1):27-32. PubMed ID: 6612770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of immune complexes in children with severe hemophilia A in substitution treatment with factor VIII concentrates].
    Körholz D; Wahn V; von Kries R; Fabry U; Göbel U
    Klin Padiatr; 1986; 198(4):306-11. PubMed ID: 3093753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Standardization of the anti-complement activity in Coombs serum].
    Fox AE
    Minerva Med; 1978 Aug; 69(37):2530-4. PubMed ID: 683607
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunodiagnostic findings in patients with kala-azar].
    Mannweiler E; Lederer I; Feldmeier H
    Dtsch Med Wochenschr; 1988 Sep; 113(37):1428-32. PubMed ID: 3046895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexes.
    Swaak AJ; Hannema A; Vogelaar C; Boom FA; van Es L; van Aalst R; Statius van Eps LW
    Rheumatol Int; 1982; 2(4):161-6. PubMed ID: 6984977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileishmania antibodies and functional activity of complement components in patients with visceral leishmaniasis in Kenya.
    Koech DK; Lyerly WH; Iha DW
    East Afr Med J; 1982 Oct; 59(10):665-70. PubMed ID: 7185558
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune complexes in preeclampsia and normal pregnancy.
    Massobrio M; Benedetto C; Bertini E; Tetta C; Camussi G
    Am J Obstet Gynecol; 1985 Jul; 152(5):578-83. PubMed ID: 3893134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patho-physiology of anemia in kala-azar (author's transl)].
    Sirol J; Laroche R; Guintran JL
    Med Trop (Mars); 1978; 38(4):399-400. PubMed ID: 732553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.
    Casali P; Lambert PH
    Clin Exp Immunol; 1979 Aug; 37(2):295-309. PubMed ID: 498587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating immune complexes and anti-IgG antibodies in rheumatoid disease. Value of C3d assay].
    Duquesnoy B; Santoro F; Siame JL; Vanhille P; Raviart B; Wattre P; Lemaitre V; Hatron PY
    Rev Med Interne; 1981; 2(1):11-6. PubMed ID: 6972076
    [No Abstract]   [Full Text] [Related]  

  • 20. The covalent interaction of C3 with IgG immune complexes.
    Vivanco F; Muñoz E; Vidarte L; Pastor C
    Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.